glp 1 agonist depression Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? The Impact of GLP-1 Receptor

Learn more about our current research grants and explore ways to support breakthrough discoveries here

Serious safety concerns are rare but include: Systemic infections : Immunocompromised individuals, those with central venous catheters, or patients with damaged gut barriers face increased risk of bacteremia or fungemia from probiotic organisms [19] [20] Antibiotic resistance transfer : Some probiotic strains may carry antibiotic resistance genes Metabolic complications : Rare cases of D-lactic acidosis have been reported with high-dose probiotic use [25] Specific populations requiring caution include patients with severe acute pancreatitis (based on the PROPATRIA trial showing increased mortality), short bowel syndrome, immunosuppression (HIV/AIDS, chemotherapy, organ transplant recipients), and critically ill individuals

In Canada, agents such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound) are rapidly becoming part of the everyday medication list

During the same period, the diagnosis of T2DM decreased by 96% among patients initiated on a GLP-1 RA outside the benefit (see Table 9 in the Appendix)

These results prove that GLP-1-based therapy may reduce inflammation and improve fatty liver disease in animal and human models